U.S. Genomics Gets $4.5M, Enters Partnership
Woburn, MA-based U.S. Genomics, a maker of single-molecule technologies for biodefense and diagnostics, announced today it has raised $4.5 million in private equity funding from Becton, Dickinson & Co. The deal marks the start of a strategic partnership between the firms to develop an infectious-disease diagnostic platform.
Trending on Xconomy
By posting a comment, you agree to our terms and conditions.